𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial

✍ Scribed by Jean-Louis Gaudin; Pascal Faure; Hubert Godinot; Françoise Gerard; Christian Trepo

Book ID
114796925
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
921 KB
Volume
15
Category
Article
ISSN
0106-9543

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled trial of a 12-mo
A randomized controlled trial of a 12-month course of recombinant human interferon-α in chronic delta (type D) hepatitis: A multicenter Italian study
✍ Floriano Rosina; Cristina Pintus; Carlton Meschievitz; Mario Rizzetto 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

To determine whether long-term therapy with recombinant interferon-a can improve the course of chronic delta hepatitis, 61 Italian patients with this disease were randomly assigned to receive either interferon-a-2b three times a week (5 MU/m2 for 4 mo and then 3 MU/m2 for another 8 mo) or no treatme

Better efficacy of a 12-month interferon
Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter, controlled, randomized trial
✍ Jean-Louis Payen; Jacques Izopet; Virginie Galindo-Migeot; Valérie Lauwers-Cance 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB 👁 2 views

We studied the efficacy of three interferon alfa-2b (IFN-2b) regimens for the retreatment of patients with chronic hepatitis C (CHC) with prior complete response followed by relapse. Consecutive patients with CHC who had a complete biochemical response but relapse after a first course of 6 months of

Lymphoblastoid interferon alfa-n1 improv
Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial
✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l

Treatment of chronic hepatitis C with re
Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial
✍ Giulio Diodati; Paola Bonetti; Franco Noventa; Carla Casarin; Massimo Rugge; Ser 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Sixty consecutive patients with chronic hepatitis C were included in a randomized controlled trial of recombinant human interferon-%, vs. no treatment. Treated patients received tapering doses of interferon thrice weekly for 1 yr. Twenty treated cases (66.7%) normalized serum aminotransferase levels